Biotech

All Articles

Novo inks $600M NanoVation package to research genetic medications ex-liver

.Novo Nordisk is proceeding its push into genetic medicines, accepting compensate NanoVation Rehabs ...

Innovent links cytokine to colorectal cancer responses

.Innovent Biologics has actually produced the case that its own gate inhibitor-cytokine fusion healt...

Merck, Daiichi ADC strikes objective in phase 3 lung cancer cells study

.A stage 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina deepens AI focus along with collab to select cancer targets

.5 months after Rakovina Rehabs rotated towards expert system, the cancer-focused biotech has partic...

Ascendis' dwarfism drug favorites in phase 3, endangers BioMarin

.Ascendis Pharma has emerged as a prospective risk to BioMarin's Voxzogo, stating phase 3 developmen...

Despite ph. 3 overlook, Alkeus finds path in advance for eye condition property

.Though Alkeus Pharmaceuticals' dental eye health condition asset failed to considerably lessen geog...

Kairos goes public with $6M IPO to money tests of cancer cells medicine

.With a triad of biotechs striking the Nasdaq on Friday, it was effortless to miss a smaller-scale p...

Vaccine and Keytruda combo efficient in squamous tissue cancer

.Immune gate inhibitors are actually the superheroes of cancer cells treatment. Medications like Bri...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings...

Regeneron's Opdualag competitor shows 57% reaction fee

.Regeneron is actually back along with long-lasting consequence for its own LAG-3 prevention and als...